Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data.
- DOI
- 10.1097/md.0000000000050189
- Published
- 2026 Aug 14
- Container
- Medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/md.0000000000050189,
title = {Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data.},
author = {Alorfi NM and Aldabbagh A and Alourfi MM and Alghamdi WS and Al Ghamdi SS and Niyazi AA and Aldekhail NM and Alkhanani MF and Ibrahim NA and Alansari AM and Ali TO and Alsolami FA and Zarroug SHO and Abdalla HK},
year = {2026},
journal = {Medicine},
doi = {10.1097/md.0000000000050189},
url = {https://doi.org/10.1097/md.0000000000050189}
}RIS
TY - JOUR TI - Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data. AU - Alorfi NM AU - Aldabbagh A AU - Alourfi MM AU - Alghamdi WS AU - Al Ghamdi SS AU - Niyazi AA AU - Aldekhail NM AU - Alkhanani MF AU - Ibrahim NA AU - Alansari AM AU - Ali TO AU - Alsolami FA AU - Zarroug SHO AU - Abdalla HK PY - 2026 JO - Medicine DO - 10.1097/md.0000000000050189 UR - https://doi.org/10.1097/md.0000000000050189 ER -
APA
NM, A., A, A., MM, A., WS, A., SS, A. G., AA, N., NM, A., MF, A., NA, I., AM, A., TO, A., FA, A., SHO, Z., & HK, A. (2026). Global pharmacovigilance overview of adverse drug reactions associated with propofol: A descriptive pharmacovigilance study using WHO-VigiAccess data.. Medicine. https://doi.org/10.1097/md.0000000000050189
Source records
- pubmed · retrieved 2026-09-26T16:50:22.678Z